Literature DB >> 21367898

Effect of an asparagine-to-serine mutation at position 294 in neuraminidase on the pathogenicity of highly pathogenic H5N1 influenza A virus.

Maki Kiso1, Makoto Ozawa, Mai Thi Quynh Le, Hirotaka Imai, Kei Takahashi, Satoshi Kakugawa, Takeshi Noda, Taisuke Horimoto, Yoshihiro Kawaoka.   

Abstract

Like the histidine-to-tyrosine substitution at position 274 in neuraminidase (NA H274Y), an asparagine-to-serine mutation at position 294 in this protein (NA N294S) confers oseltamivir resistance to highly pathogenic H5N1 influenza A viruses. However, unlike viruses with the NA H274Y mutation, the properties of viruses possessing NA N294S are not well understood. Here, we assessed the effect of the NA N294S substitution on the replication and pathogenicity of human H5N1 viruses and on the efficacy of the NA inhibitors oseltamivir and zanamivir in mouse and ferret models. Although NA N294S-possessing H5N1 viruses were attenuated in mice and ferrets compared to their oseltamivir-sensitive counterparts, one of the infected ferrets died from systemic infection, demonstrating the potential lethality in ferrets of oseltamivir-resistant H5N1 viruses with the NA N294S substitution. The efficacy of oseltamivir, but not that of zanamivir, against an NA N294S-possessing virus was substantially impaired both in ferrets and in vitro. These results demonstrate the considerable pathogenicity of NA N294S substitution-possessing H5N1 viruses and underscore the importance of monitoring the emergence of the NA N294S mutation in circulating H5N1 viruses.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21367898      PMCID: PMC3126218          DOI: 10.1128/JVI.00047-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

Review 1.  Perspectives on antiviral use during pandemic influenza.

Authors:  F G Hayden
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-12-29       Impact factor: 6.237

2.  Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection.

Authors:  R B Belshe; M H Smith; C B Hall; R Betts; A J Hay
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

Review 3.  Peramivir (BCX-1812, RWJ-270201): potential new therapy for influenza.

Authors:  Robert W Sidwell; Donald F Smee
Journal:  Expert Opin Investig Drugs       Date:  2002-06       Impact factor: 6.206

4.  Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness.

Authors:  K Subbarao; A Klimov; J Katz; H Regnery; W Lim; H Hall; M Perdue; D Swayne; C Bender; J Huang; M Hemphill; T Rowe; M Shaw; X Xu; K Fukuda; N Cox
Journal:  Science       Date:  1998-01-16       Impact factor: 47.728

5.  Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants.

Authors:  L V Gubareva; R G Webster; F G Hayden
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

6.  Resistant influenza A viruses in children treated with oseltamivir: descriptive study.

Authors:  Maki Kiso; Keiko Mitamura; Yuko Sakai-Tagawa; Kyoko Shiraishi; Chiharu Kawakami; Kazuhiro Kimura; Frederick G Hayden; Norio Sugaya; Yoshihiro Kawaoka
Journal:  Lancet       Date:  2004 Aug 28-Sep 3       Impact factor: 79.321

7.  Molecular basis of resistance of influenza A viruses to amantadine.

Authors:  A J Hay; M C Zambon; A J Wolstenholme; J J Skehel; M H Smith
Journal:  J Antimicrob Chemother       Date:  1986-10       Impact factor: 5.790

Review 8.  Influenza virus neuraminidase inhibitors.

Authors:  L V Gubareva; L Kaiser; F G Hayden
Journal:  Lancet       Date:  2000-03-04       Impact factor: 79.321

9.  High frequency of resistant viruses harboring different mutations in amantadine-treated children with influenza.

Authors:  Kyoko Shiraishi; Keiko Mitamura; Yuko Sakai-Tagawa; Hideo Goto; Norio Sugaya; Yoshihiro Kawaoka
Journal:  J Infect Dis       Date:  2003-06-23       Impact factor: 5.226

10.  Characterization of oseltamivir-resistant 2009 H1N1 pandemic influenza A viruses.

Authors:  Maki Kiso; Kyoko Shinya; Masayuki Shimojima; Ryo Takano; Kei Takahashi; Hiroaki Katsura; Satoshi Kakugawa; Mai Thi Quynh Le; Makoto Yamashita; Yousuke Furuta; Makoto Ozawa; Yoshihiro Kawaoka
Journal:  PLoS Pathog       Date:  2010-08-26       Impact factor: 6.823

View more
  20 in total

1.  Epidemiological and genetic characteristics of the fifth avian influenza A(H7N9) wave in Suzhou, China, from October 2016 to April 2017.

Authors:  Zefeng Dong; Yu Xia; Xuerong Ya; Liling Chen; Cheng Liu; Ruyan Wang; Qiang Shen
Journal:  Virus Genes       Date:  2018-02-05       Impact factor: 2.332

Review 2.  Fitness of neuraminidase inhibitor-resistant influenza A viruses.

Authors:  Tatiana Baranovich; Robert G Webster; Elena A Govorkova
Journal:  Curr Opin Virol       Date:  2011-10-01       Impact factor: 7.090

3.  Decreased neuraminidase activity is important for the adaptation of H5N1 influenza virus to human airway epithelium.

Authors:  Natalia A Ilyushina; Nicolai V Bovin; Robert G Webster
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

4.  Neuraminidase Mutations Conferring Resistance to Oseltamivir in Influenza A(H7N9) Viruses.

Authors:  Henju Marjuki; Vasiliy P Mishin; Anton P Chesnokov; Juan A De La Cruz; Charles T Davis; Julie M Villanueva; Alicia M Fry; Larisa V Gubareva
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

Review 5.  Consequences of resistance: in vitro fitness, in vivo infectivity, and transmissibility of oseltamivir-resistant influenza A viruses.

Authors:  Elena A Govorkova
Journal:  Influenza Other Respir Viruses       Date:  2013-01       Impact factor: 4.380

6.  Antiviral resistance among highly pathogenic influenza A (H5N1) viruses isolated worldwide in 2002-2012 shows need for continued monitoring.

Authors:  Elena A Govorkova; Tatiana Baranovich; Patrick Seiler; Jianling Armstrong; Andrew Burnham; Yi Guan; Malik Peiris; Richard J Webby; Robert G Webster
Journal:  Antiviral Res       Date:  2013-02-28       Impact factor: 5.970

Review 7.  H5N1 pathogenesis studies in mammalian models.

Authors:  Jessica A Belser; Terrence M Tumpey
Journal:  Virus Res       Date:  2013-02-28       Impact factor: 3.303

8.  The Path of Least Resistance: Mechanisms to Reduce Influenza's Sensitivity to Oseltamivir.

Authors:  Angela M Phillips; Matthew D Shoulders
Journal:  J Mol Biol       Date:  2015-12-31       Impact factor: 5.469

9.  Correlation between Virus Replication and Antibody Responses in Macaques following Infection with Pandemic Influenza A Virus.

Authors:  Gerrit Koopman; Petra Mooij; Liesbeth Dekking; Daniëlla Mortier; Ivonne G Nieuwenhuis; Melanie van Heteren; Harmjan Kuipers; Edmond J Remarque; Katarina Radošević; Willy M J M Bogers
Journal:  J Virol       Date:  2015-11-04       Impact factor: 5.103

10.  Detection sensitivity of influenza rapid diagnostic tests.

Authors:  Yuko Sakai-Tagawa; Makoto Ozawa; Shinya Yamada; Yuko Uchida; Takehiko Saito; Kazuo Takahashi; Norio Sugaya; Masato Tashiro; Yoshihiro Kawaoka
Journal:  Microbiol Immunol       Date:  2014-10       Impact factor: 1.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.